Influence of Bacillus Calmette-Guerin on Expression of GATA-3 in Lung of Asthmatic Mouse

XIA Yu,ZHANG Jian-hua,ZHU Xue-ming,WANG Xing-dong,LI Xiao-di,YU Zhi-wei,LIU Hai-yan
DOI: https://doi.org/10.3969/j.issn.1003-515x.2007.04.026
2007-01-01
Abstract:Objective To evaluate the influence of bacillus calmette-guarin(BCG) treament on the airway inflammation and expression of GATA-3 in lung of asthmatic mouse.Methods Twenty-four Kunming mouse were randomly divided into asthma group,BCG treatment group and control group.The mouse were sensitized and challenged with ovalbumin(OVA) to establish asthmatic model.The mouse in BCG treatment group were injected intradermally with BCG 5 days before and after sensitization.The number of total cells and eosinophils in BALF were counted.The concentration of cytokine IL-4 in BALF was determined by enzyme linked immunosorbent assay(ELISA).The expression of GATA-3 in the lung was observed by immunohistochemistry.Results 1.The number of total cells and eosinophils in BALF of asthma group were significantly higher than those of control group(Pa<0.001);the number of total cells and eosinophils in BALF of BCG treament group were significantly lower than those of asthmatic mouse(Pa<0.001).2.The concentration of IL-4 in BALF of asthma group was significantly higher than that of control group(P<0.01);the level of IL-4 in BALF of asthma mouse treated with BCG treament decreased compared with asthmatic mouse(P<0.01).3.Immunohistochemical staining of lung sections showed that expression of GATA-3 in asthmatic mouse was stronger than that of BCG-treated mouse.Conclusion BCG can inhibit the expression of GATA-3 in lung of asthmatic mouse,which resulted in TH2 cytokine decrease and relief of airway inflammation.
What problem does this paper attempt to address?